Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.

Medwid S, Li MMJ, Knauer MJ, Lin K, Mansell SE, Schmerk CL, Zhu C, Griffin KE, Yousif MD, Dresser GK, Schwarz UI, Kim RB, Tirona RG.

Drug Metab Dispos. 2019 Aug;47(8):832-842. doi: 10.1124/dmd.119.087619. Epub 2019 May 23.

PMID:
31123035
2.

Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients.

Cattral M, Luke S, Knauer MJ, Norgate A, Schiff J, Muirhead N, Luke PP.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13180. Epub 2018 Jan 29.

PMID:
29266398
3.

Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer.

Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V.

Version 2. F1000Res. 2017 Oct 13 [revised 2017 Jan 1];6:1832. doi: 10.12688/f1000research.12775.2. eCollection 2017.

4.

Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?

Knauer MJ, Diamandis EP, Hulot JS, Kim RB, So DY.

Clin Chem. 2015 Oct;61(10):1235-40. doi: 10.1373/clinchem.2015.238105. Epub 2015 Aug 13. No abstract available.

5.

Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients.

Urquhart BL, Knauer MJ.

Pediatr Transplant. 2015 Feb;19(1):3-4. doi: 10.1111/petr.12394. No abstract available.

PMID:
25546506
6.

Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms.

Thomson BK, Nolin TD, Velenosi TJ, Feere DA, Knauer MJ, Asher LJ, House AA, Urquhart BL.

Am J Kidney Dis. 2015 Apr;65(4):574-82. doi: 10.1053/j.ajkd.2014.09.015. Epub 2014 Nov 21.

PMID:
25453994
7.

Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2B1 transcriptional start site variant.

Knauer MJ, Girdwood AJ, Kim RB, Tirona RG.

Mol Pharmacol. 2013 Jun;83(6):1218-28. doi: 10.1124/mol.112.083618. Epub 2013 Mar 26.

PMID:
23531488
8.

Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response.

Gong IY, Crown N, Suen CM, Schwarz UI, Dresser GK, Knauer MJ, Sugiyama D, DeGorter MK, Woolsey S, Tirona RG, Kim RB.

Eur Heart J. 2012 Nov;33(22):2856-2464a. doi: 10.1093/eurheartj/ehs042. Epub 2012 Feb 27.

PMID:
22374717
9.

Human skeletal muscle drug transporters determine local exposure and toxicity of statins.

Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, Kim RB, Tirona RG.

Circ Res. 2010 Feb 5;106(2):297-306. doi: 10.1161/CIRCRESAHA.109.203596. Epub 2009 Nov 25.

PMID:
19940267
10.

The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs.

Urquhart BL, Gregor JC, Chande N, Knauer MJ, Tirona RG, Kim RB.

Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G248-54. doi: 10.1152/ajpgi.00224.2009. Epub 2009 Sep 17.

Supplemental Content

Loading ...
Support Center